ALS Research Collaborative
Part of paid clinical trials in Watertown, Massachusetts.
- Sponsor
- ALS Therapy Development Institute
- Study ID
- NCT06885918
- Status
- Recruiting
Conditions
- ALS (Amyotrophic Lateral Sclerosis)
- ALS With Frontotemporal Dementia (ALS/FTD)
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
Key Dates
- Start date
- Sep 12, 2014
- Status verified
- Mar 2025
- Primary completion
- Jan 31, 2035
- Completion
- Jan 31, 2035
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Person living with ALS/MNDAn adult over the age of 18, that has received a diagnosis of ALS or other Motor Neuron Disease from a practicing physician.
- Arm: Asymptomatic gene carrierAn adult over the age of 18 who does not have symptoms of ALS and carries a mutation known to be associated with ALS
- Arm: Healthy VolunteerAn adult over the age of 18 who does not have any biological connection to ALS or other Motor Neuron Disease, and no significant health problems.
Primary Outcome Measure
ALS Functional Rating Scale - Revised (ALSFRS-R) [ Time Frame: Monthly, through study completion, an average of 1 year ]
Central Contacts
- Alan S Premasiri, M.S.617-441-7200
- Beth Levine617-441-7200
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ALS Therapy Development Institute | Watertown | Massachusetts | 02472 | Fernando G Vieira, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Watertown, MA
By research site
Related Studies
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruiting · Leigh R. Hochberg, MD, PhD. · Sacramento, California
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsPHASE3 · Recruiting · AB Science · Birmingham, Alabama
- RAPA-501 Therapy for ALSPHASE2/PHASE3 · Recruiting · Rapa Therapeutics LLC · Boston, Massachusetts
- HEALEY ALS Platform Trial - Master ProtocolPHASE2/PHASE3 · Recruiting · Merit E. Cudkowicz, MD · Phoenix, Arizona